Hey there, lab enthusiasts! Boost your research efficiency with AI-powered literature insights at your fingertips. Download the科研喵app, available at labcat.com.cn, and get ready to multiply your productivity. In yesterday's top article from Clinical Microbiology Reviews, researchers delve into the intricacies of BCG therapy for non-muscle-invasive bladder cancer. Despite decades of use, BCG's mechanisms remain elusive, and resistance is a growing concern. This comprehensive review breaks down BCG's direct tumor effects and its complex dance with the bladder tumor microenvironment, including its intriguing interaction with the bladder microbiome. The study also spotlights novel strategies to overcome BCG resistance, from recombinant BCG to microbiota-targeted therapies, aiming to enhance treatment efficacy and reduce side effects. As the only bacterial drug approved for cancer treatment, BCG's lessons could pave the way for the next generation of bacterial cancer therapies. Tune in for a deep dive into this fascinating frontier of cancer research!
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other recent transcribed episodes
Transcribed and ready to explore now
Before the Crisis: How You and Your Relatives Can Prepare for Financial Caregiving
06 Dec 2025
Motley Fool Money
OpenAI's Code Red, Sacks vs New York Times, New Poverty Line?
06 Dec 2025
All-In with Chamath, Jason, Sacks & Friedberg
Anthropic Finds AI Answers with Interviewer
05 Dec 2025
The Daily AI Show
#2423 - John Cena
05 Dec 2025
The Joe Rogan Experience
Warehouse to wellness: Bob Mauch on modern pharmaceutical distribution
05 Dec 2025
McKinsey on Healthcare
The method of invention, AI's new clock speed and why capital markets are confused
05 Dec 2025
Azeem Azhar's Exponential View